Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake

Status Completed

Clinical Trial Summary

The overall goals of this study are to (1) expand knowledge about interactions of chlorzoxazone with alcohol by assessing the effects of chlorzoxazone compared to placebo in moderate and heavy social alcohol users and (2) to compare the effects of chlorzoxazone on visual cue induced alcohol craving to placebo in moderate to heavy social alcohol users.

Clinical Trial Description

The investigators propose a 45-day, double-blind, placebo-controlled crossover study in light to moderate and heavy alcohol users. The specific aims are to: 1. Determine if chlorzoxazone alters daily alcohol consumption by comparing the mean drinks consumed per day during chlorzoxazone administration compared with the mean drinks per day consumed during placebo administration. 2. To determine if polymorphisms in genes encoding for neurotransmitters or receptors involved in alcohol reward, abuse, dependence, craving, or relapse may predict the level of response to chlorzoxazone's effects on alcohol consumption or craving. 3. To investigate any change in alcohol craving during a cue induced craving task where participants view and respond to a number of images. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01342341
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	Phase 4
Start date	April 2011
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03165942` - Neuroendocrine Response to Oral Alcohol Administration	Phase 1
Recruiting	`NCT05343039` - Technology Enhanced Adolescent Mental Health (TEAM)	N/A
Active, not recruiting	`NCT04070521` - EEG Monitoring in the Emergency Department
Completed	`NCT03169244` - Buproprion for Binge Drinking	Phase 2
Recruiting	`NCT05246202` - Personalized Feedback Intervention for Latinx Drinkers With Anxiety	N/A
Completed	`NCT05036499` - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain	N/A
Recruiting	`NCT04368416` - Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Not yet recruiting	`NCT04557631` - Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
Terminated	`NCT00890149` - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults	Phase 2
Completed	`NCT02448134` - A Community-Based Strategy for Preventing Underage Drinking	N/A
Completed	`NCT02179749` - Mifepristone Treatment of Alcohol Use Disorder	Phase 2
Completed	`NCT02681406` - Smartphone Based Continuing Care for Alcohol	N/A
Withdrawn	`NCT01847300` - cSBI-M for Young Military Personnel	N/A
Withdrawn	`NCT01796158` - Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use	N/A
Completed	`NCT01553136` - Varenicline Treatment of Alcohol Dependence in Smokers	Phase 2
Terminated	`NCT01408641` - Topiramate for Alcohol Use in Posttraumatic Stress Disorder	N/A
Withdrawn	`NCT01511679` - Brain-imaging and Adolescent Neuroscience Consortium	N/A
Withdrawn	`NCT01275391` - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use	Phase 1/Phase 2
Active, not recruiting	`NCT01539525` - Screening to Augment Referral to Treatment- Project START	Phase 2
Completed	`NCT01207258` - Brief Intervention for Problem Drinking and Partner Violence	Phase 2